Increased Brain Monocarboxylic Acid Transport and Utilization in Type 1 Diabetes
Increased Brain Monocarboxylic Acid Transport and Utilization in Type 1 Diabetes Graeme F. Mason 1 2 , Kitt F. Petersen 3 , Vincent Lebon 4 , Douglas L. Rothman 2 5 and Gerald I. Shulman 3 6 1 Department of Psychiatry and Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut 2 Depart...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 55; no. 4; pp. 929 - 934 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.04.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Increased Brain Monocarboxylic Acid Transport and Utilization in Type 1 Diabetes
Graeme F. Mason 1 2 ,
Kitt F. Petersen 3 ,
Vincent Lebon 4 ,
Douglas L. Rothman 2 5 and
Gerald I. Shulman 3 6
1 Department of Psychiatry and Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut
2 Department of Diagnostic Radiology, Yale School of Medicine, New Haven, Connecticut
3 Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
4 Groupe de Spectroscopie RMN, Unité d’Imagerie Isotopique Biochimique et Pharmacologique, Orsay Cedex, France
5 Department of Biomedical Engineering, Yale School of Medicine, New Haven, Connecticut
6 Department of Cellular and Molecular Physiology, Howard Hughes Medical Institute, Yale School of Medicine, New Haven, Connecticut
Address correspondence and reprint requests to Dr. Gerald I. Shulman, Howard Hughes Medical Institute, Yale University School
of Medicine, TAC S-269, P.O. Box 9812, New Haven, CT 06536-8012. E-mail: gerald.shulman{at}yale.edu
Abstract
We hypothesized that increased capacity for brain utilization of nonglucose substrates (monocarboxylic acids [MCAs]) by upregulation
of the MCA transporters may contribute metabolic substrates during hypoglycemia. To test this hypothesis, we assessed brain
acetate metabolism in five well-controlled type 1 diabetic subjects and six nondiabetic control subjects using 13 C magnetic resonance spectroscopy during infusions of [2- 13 C]acetate during hypoglycemia (∼55 mg/dl). Acetate is transported into the brain through MCA transporters that are also used
for lactate and ketones. Brain acetate concentrations were over twofold higher in the subjects with diabetes than the control
subjects ( P = 0.01). The fraction of oxidative metabolism from acetate ( P = 0.015) and the rate of MCA transport ( P = 0.01) were also approximately twofold higher in the diabetic subjects. We conclude that during hypoglycemia MCA transport
in the brain was increased by appoximately twofold in patients with well-controlled type 1 diabetes, as reflected by higher
brain acetate concentrations and rates of acetate oxidation. This upregulation would potentially allow a similar twofold increase
in the transport of other MCAs, including lactate, during insulin-induced hypoglycemia. These data are consistent with the
hypothesis that upregulation of MCA transport may contribute to the maintenance of brain energetics during hypoglycemia in
patients with type 1 diabetes.
MCA, monocarboxylic acid
MRS, magnetic resonance spectroscopy
PET, positron emission tomography
TCA, tricarboxylic acid
Footnotes
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Accepted January 5, 2006.
Received October 11, 2005.
DIABETES |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.55.04.06.db05-1325 |